Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No. 24, Yamen Street, Velenjak, Tehran, Iran.
Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
BMC Endocr Disord. 2023 Aug 30;23(1):186. doi: 10.1186/s12902-023-01439-7.
Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor that originates from parafollicular C-cells. Calcitonin (Ctn) and carcinoembryonic antigen (CEA) are useful biomarkers for monitoring MTC cases.
Here, we describe a 48-year-old woman, who presented in 2014 with bilateral thyroid nodules. Report of fine needle aspiration was suspicious for MTC; initial laboratory evaluation showed serum Ctn level of 1567 pg/mL. After excluding type 2 multiple endocrine neoplasia syndrome clinically, total thyroidectomy and neck lymph node dissection were performed. The final histopathological diagnosis was right lobe MTC with neither vascular invasion nor lymph node involvement. On regular follow-up visits, Ctn and CEA levels have been undetectable, and repeated cervical ultrasonographic exams were unremarkable from 2014 to 2021. As liver enzymes became elevated in 2016, the patient was further evaluated by a gastroenterologist. Abdominopelvic ultrasonography revealed a coarse echo pattern of the liver parenchyma with normal bile ducts. A liver fibroscan showed a low fibrosis score (7kPa). The patient was recommended to use ursodeoxycholic acid. According to the progressive rise of liver enzymes with a cholestatic pattern in October 2020, a liver biopsy was performed that showed tiny nests of neuroendocrine-like cells with a background of primary biliary cholangitis (PBC). Immunohistochemical stainings were positive for chromogranin A (CgA), and synaptophysin and negative for Ctn, CEA, and thyroglobulin. Further imaging investigations did not reveal any site of a neuroendocrine tumor in the body. Considering normal physical exam, imaging findings, as well as normal serum levels of Ctn, CEA, CgA, and procalcitonin, the patient was managed as a PBC.
In follow-up of a patient with MTC, we reported progressively increased liver enzymes with a cholestatic pattern. Liver biopsy revealed nests of neuroendocrine-like cells with a background of PBC, the findings that might suggest acquiring neuroendocrine phenotype by proliferating cholangiocytes.
髓样甲状腺癌(MTC)是一种起源于滤泡旁 C 细胞的神经内分泌肿瘤。降钙素(Ctn)和癌胚抗原(CEA)是监测 MTC 病例的有用生物标志物。
这里,我们描述了一位 48 岁女性,她于 2014 年因双侧甲状腺结节就诊。细针穿刺抽吸报告提示为 MTC 可疑;初步实验室检查显示血清 Ctn 水平为 1567 pg/mL。在临床上排除 2 型多发性内分泌肿瘤综合征后,进行了全甲状腺切除术和颈部淋巴结清扫术。最终的组织病理学诊断为右叶 MTC,无血管侵犯和淋巴结受累。在定期随访中,Ctn 和 CEA 水平一直无法检测到,并且 2014 年至 2021 年重复的颈部超声检查均无异常。由于 2016 年肝功能酶升高,患者进一步接受了胃肠病学家的评估。腹部超声显示肝实质回声粗糙,胆管正常。肝脏 Fibroscan 显示低纤维化评分(7kPa)。建议患者使用熊去氧胆酸。2020 年 10 月,由于胆汁淤积模式的肝酶逐渐升高,进行了肝活检,结果显示原发性胆汁性胆管炎(PBC)背景下存在微小的神经内分泌样细胞巢。免疫组化染色显示嗜铬粒蛋白 A(CgA)阳性,降钙素、CEA 和甲状腺球蛋白阴性。进一步的影像学检查未发现体内任何神经内分泌肿瘤部位。考虑到患者体格检查正常、影像学结果正常以及血清 Ctn、CEA、CgA 和降钙素原水平正常,患者被诊断为 PBC 并接受管理。
在 MTC 患者的随访中,我们报告了逐渐升高的伴有胆汁淤积模式的肝功能酶。肝活检显示 PBC 背景下存在神经内分泌样细胞巢,这一发现可能提示增殖的胆管细胞获得了神经内分泌表型。